Literature DB >> 19279283

MR imaging identification of oligodendroglial hyperplasia.

B E Hamilton1, G M Nesbit.   

Abstract

SUMMARY: We report a case of oligodendroglial hyperplasia detected by using high-resolution high-field MR imaging. This disorder is considered part of the spectrum of cortical migrational abnormalities and is found with increased incidence in patients with epilepsy. Surgery offers the best chance for cure in patients with medically refractory partial complex epilepsy. Accurate localization and detection of the full lesion extent by using a high-resolution imaging technique such as 3T MR imaging is important to surgical success. Detection of subtle dysplastic lesions such as oligodendroglial hyperplasia may be clinically relevant.

Entities:  

Mesh:

Year:  2009        PMID: 19279283     DOI: 10.3174/ajnr.A1522

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

1.  MRI, Magnetoencephalography, and Surgical Outcome of Oligodendrocytosis versus Focal Cortical Dysplasia Type I.

Authors:  D Mata-Mbemba; Y Iimura; L-N Hazrati; A Ochi; H Otsubo; O C Snead; J Rutka; E Widjaja
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-15       Impact factor: 3.825

2.  Epileptic Patient with Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia and Epilepsy (MOGHE): A Case Report and Review of the Literature.

Authors:  A Verentzioti; I Blumcke; A Alexoudi; P Patrikelis; A Siatouni; S Korfias; D Sakas; S Gatzonis
Journal:  Case Rep Neurol Med       Date:  2019-06-09

3.  Post-Operative Seizure Freedom Need not be Elusive in Mild Oligodendroglial Hyperplasia and Epilepsy (MOGHE).

Authors:  Aparajita Chatterjee; Ravindranadh C Mundlamuri; Ajay Asranna; Raghavendra Kenchaiah; G K Bhargava; Mariyappa Narayanan; Radhika Mhatre; Karthik Kulanthaivelu; Sandhya Mangalore; Chandana Nagaraj; Rose Dawn Bharath; Jitender Saini; Nishanth Sadashiva; A Arivazhagan; Malla Bhaskara Rao; Anita Mahadevan; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2021-08-04       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.